Skip to main content

Mental Note: People to Befriend

The Wall Street Journal's 2008 CEO compensation survey is out. Most of the pharma CEOs make in the $16 million to $18 million range, and the highest-paid person on the list of pharma execs is Abbott's Miles White, who receives a little more than $18 million. Eli Lilly's new CEO, John Lechleiter, may feel a little shafted with a compensation package worth about $10 million.

The Scan

Not Kept "Clean and Sanitary"

A Food and Drug Administration inspection uncovered problems with cross contamination at an Emergent BioSolutions facility, the Wall Street Journal reports.

Resumption Recommendation Expected

The Washington Post reports that US officials are expected to give the go-ahead to resume using Johnson & Johnson's SARS-CoV-2 vaccine.

Canada's New Budget on Science

Science writes that Canada's new budget includes funding for the life sciences, but not as much as hoped for investigator-driven research.

Nature Papers Examine Single-Cell, Multi-Omic SARS-CoV-2 Response; Flatfish Sequences; More

In Nature this week: single-cell, multi-omics analysis provides insight into COVID-19 pathogenesis, evolution of flatfish, and more.